Ferric carboxymaltose is a colloidal iron preparation embedded within a carbohydrate polymer. It provides a source of iron for the synthesis of hemoglobin and replenishment of iron stores, particularly when oral iron therapy is unsuccessful due to intolerance, poor absorption, or ongoing blood loss.
Iron deficiency when oral therapy is unsuccessful (e.g., patient cannot tolerate oral iron, does not take it reliably, continuing blood loss, malabsorption)Management of chemotherapy-induced anaemia (when given with erythropoietins)Chronic renal failure patients (including those on haemodialysis or peritoneal dialysis) requiring intravenous ironAnaemia patients for rapid increase in haemoglobin level and replenishment of storesiron deficiency in heart failure (NYHA class II–III, hemoglobin levels of 9.5 to 13.5 g/dL)iron deficiency anemia in patients with intolerance to oral ironiron deficiency anemia in patients with unsatisfactory response to oral ironiron deficiency anemia in patients with non–dialysis-dependent chronic kidney diseaseIron deficiency anaemiaWhen oral iron is not toleratedFailure to absorb oral iron (malabsorption, inflammatory bowel disease, chronic inflammation)Non-compliance to oral ironSevere deficiency with chronic bleedingAlong with erythropoietin (to meet demands of induced rapid erythropoiesis)
- Adult
- iron is given as a total dose or in divided doses. Further treatment should be guided by monitoring haemoglobin and serum iron concentrations.…
- Pediatric
- not recommended for children <14 years
- Serious hypersensitivity reactions to intravenous iron, including life-threatening and fatal anaphylactic reactions
- Iron overload (due to parenteral administration bypassing regulatory mechanisms)
- i.m. injection
Common
Pain at injection siteRashesHeadacheNauseaAbdominal painHypotension (infrequent)Flushing (infrequent)Chest pain (infrequent)dizzinessconstipationdiarrhearashinjection site reactions
Serious
- Serious hypersensitivity reactions
- Life-threatening and fatal anaphylactic reactions (rare)
- anaphylaxis (rare)
and used in the second or third
DimercaprolSevere
Database
Clinical effect not specified
Source: DDInter
ErdafitinibSevere
Database
Clinical effect not specified
Source: DDInter
10 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.